Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1474

PDF: 940

HTML: 342
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

1905

PDF: 351

HTML: 1
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

943

pdf: 470

HTML: 128
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

1977

PDF: 929

HTML: 1232
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1721

PDF: 1469

Appendix: 687

HTML: 544
Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

https://doi.org/10.4081/itjm.2013.234

1099

PDF: 868

HTML: 304
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1394

PDF: 974
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1593

PDF: 1258

Appendix: 579

HTML: 622
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.1

11573

PDF: 2928
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

932

PDF: 832
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.29

1077

PDF: 858
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

https://doi.org/10.4081/itjm.2013.88

1185

PDF: 672

HTML: 220
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1322

PDF: 905
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

2631

PDF: 1067

HTML: 82
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.59

934

PDF: 916
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

1020

PDF: 370

SUPPLEMENTARY MATERIAL: 232

ACKNOWLEDGMENTS: 220

HTML: 112
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1280

PDF: 894
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1188

PDF: 1891
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

1917

PDF: 1125

HTML: 586
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.22

1006

PDF: 757
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1359

PDF: 697

HTML: 266
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

https://doi.org/10.4081/itjm.2014.504

2126

PDF: 1357

Appendix: 1100

HTML: 757
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1689

PDF: 2014
Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

Paolo Biagi, Roberto Nardi, Concetta Isabella Baldo, Giovanni Scanelli, Domenico Panuccio, Andrea Bonanome, Fabio Miserocchi, Luigi Lusiani, Erminio Bonizzoni, Mauro Campanini, Carlo Nozzoli, Giorgio Vescovo, on behalf of the FADOI-CONFINE Study Group

19-28

17-03-2014

https://doi.org/10.4081/itjm.2014.394

2036

PDF: 1127

HTML: 657
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.36

931

PDF: 836
Clinical management of spontaneous intracranial haemorrhage associated with oral anticoagulants: a case series

Luca Masotti, Alessandro Pampana, Paolo Pennati, Giancarlo Landini

34-44

07-03-2013

https://doi.org/10.4081/itjm.2011.34

779

PDF: 1026
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

https://doi.org/10.4081/itjm.2017.705

1386

PDF: 748

HTML: 451
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

https://doi.org/10.4081/itjm.2018.893

2075

PDF: 918

HTML: 461
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

https://doi.org/10.4081/itjm.2013.196

1878

PDF: 1101

HTML: 1924
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

828

PDF: 538

HTML: 361
Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Andrea Donti

175-184

30-09-2016

https://doi.org/10.4081/itjm.2016.676

1601

PDF: 947

HTML: 924
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

https://doi.org/10.4081/itjm.2020.1224

953

PDF: 634

HTML: 198
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

https://doi.org/10.4081/itjm.2016.690

1670

PDF: 874

HTML: 803
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

https://doi.org/10.4081/itjm.2015.629

1620

PDF: 917

HTML: 254
The heart failure in Internal Medicine in Tuscany: the SMIT Study

Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

349-355

15-12-2015

https://doi.org/10.4081/itjm.2015.554

1649

PDF: 910

Appendix: 1015

HTML: 757
Differences in in-hospital clinical course, management and outcome between stroke with and without atrial fibrillation. A retrospective analysis from the SETI (Studio Epidemiologico Toscano Ictus) study

P. Biagi, S. Bocchini, R. Laureano, G. Panigada, G. Vescovo

14-22

03-05-2013

https://doi.org/10.4081/itjm.2007.4.14

1010

PDF: 774
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

https://doi.org/10.4081/itjm.2021.1351

1147

PDF: 541

HTML: 54
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

https://doi.org/10.4081/itjm.2024.1718

640

PDF: 430

HTML: 72
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

https://doi.org/10.4081/itjm.2015.669

2126

PDF: 891

Appendix: 475

HTML: 1459
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

https://doi.org/10.4081/itjm.2017.748

2708

PDF: 1212

HTML: 1342
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

https://doi.org/10.4081/itjm.2013.96

2131

PDF: 926

HTML: 472
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

https://doi.org/10.4081/itjm.2019.1111

1394

PDF: 791

HTML: 71
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1494

PDF: 1789

HTML: 260
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

99-109

08-05-2014

https://doi.org/10.4081/itjm.2014.400

2262

PDF: 1378

HTML: 717
Abdominal pain: a synthesis of recommendations for its correct management

Daniela Tirotta, Annalisa Marchetti, Mariangela Di Lillo, Fulvio Pomero, Roberta Re, Michele Meschi, Domenico Montemurro, Paola Gnerre, Chiara Bozzano, Micaela La Regina

193-202

08-05-2015

https://doi.org/10.4081/itjm.2015.515

3825

PDF: 1447

Appendix: 551

HTML: 8941
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

https://doi.org/10.4081/itjm.2023.1656

1005

PDF: 350

HTML: 30
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

https://doi.org/10.4081/itjm.2023.1573

1939

PDF: 573

HTML: 13
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

https://doi.org/10.4081/itjm.2016.738

1331

PDF: 862

HTML: 380
The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

246-252

27-12-2016

https://doi.org/10.4081/itjm.2016.713

1435

PDF: 983

HTML: 289
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

218-230

19-09-2013

https://doi.org/10.4081/itjm.2013.218

1474

PDF: 1079

HTML: 854

1 - 50 of 52 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy